Back to results
US 2025/0144066 A1Published application
Prevention and Treatment of Parasitic Infections
OwnerSteven BARANOWITZinventor
Life of this patent
Estimating the term…
Abstract
The present disclosure provides for treatment of parasitic infections. It does this using agents and methods with little toxicity compared to existing therapies.
Claims18
A method of treating a parasitic infection in a patient, the method comprising the steps of:
- selecting a patient in need of treating a parasitic infection;
- and
- administering to the patient at least one agent which depletes guanosine-containing nucleosides and nucleotides,
- wherein the parasitic infection is treated in the patient.
1 more element
A method of treating a parasitic infection in a patient, the method comprising the steps of:
- selecting a patient in need of treating a parasitic infection;
- and
- administering to the patient at least one agent selected from the group consisting of minocycline, doxycycline, tetracycline, tetracycline derivatives, and combinations thereof,
- wherein the parasitic infection is treated in the patient.
1 more element
A method of preventing and/or treating a parasitic infection in a patient, the method comprising the steps of:
- selecting a patient in need of preventing and/or treating a viral infection;
- and
- administering to the patient at least one first agent which depletes guanosine-containing nucleosides and nucleotides and at least one additional agent selected from the group consisting of minocycline, doxycycline, tetracycline, tetracycline derivatives, and combinations thereof,
- wherein the parasitic infection is prevented and/or treated in the patient.
1 more element
A pharmaceutical composition comprising:
- (i) at least one first agent which depletes guanosine-containing nucleosides and nucleotides;
- and
- (ii) at least one second agent selected from the group consisting of minocycline, doxycycline, tetracycline, tetracycline derivatives, L-DOPA, dopamine, and combinations thereof;
- wherein the pharmaceutical composition further comprises at least one pharmaceutically acceptable excipient.
1 more element
Dependencies are inferred from the claim text.